Fundz

Twentyeight Seven, Inc. reported raising $25.1 Million in an initial SEC Form D filing, from an offering of $65.2 Million

PRIVATESep 06, 2018$25.1M of $65.2M raised

Amount Raised

$25.1 Million

$25.1 Million sold, per SEC Form D (first sale Sep 6, 2018)

Round Type

Venture

WatertownBiotechnology

Quick answer

Twentyeight-Seven raised $25.1 Million in a funding round, dated September 6, 2018. Twentyeight-Seven is based in Watertown, Massachusetts, United States.

How much did Twentyeight-Seven raise?
Twentyeight-Seven raised $25.1 Million in a funding round on September 6, 2018.
What does Twentyeight-Seven do?
Previous name of Redona Therapeutics, Inc. is Twentyeight-Seven, Inc. Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases.
Where is Twentyeight-Seven based and how big is it?
Twentyeight-Seven is based in Watertown, Massachusetts, United States.
Who are the decision-makers at Twentyeight-Seven?
Fundz holds 1 contact at Twentyeight-Seven. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Twentyeight-Seven that raised within 45 days of this round, from Fundz verified event records.

Who to call at Twentyeight-Seven, and when

A new round usually means Twentyeight-Seven is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Twentyeight-Seven raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Twentyeight-Seven, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Twentyeight-Seven. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Twentyeight-Seven

Location

490 Arsenal Way

Watertown, Massachusetts, United States

About

Previous name of Redona Therapeutics, Inc. is Twentyeight-Seven, Inc. Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Twentyeight-Seven raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts12 people are listed at Twentyeight-Seven. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Twentyeight-Seven's next move

See what Strategic adds

Twentyeight-Seven raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.